These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 14091096)

  • 1. [CARCINOMA OF THE CERVIX UTERI AND PELVIC TUBERCULOSIS].
    REGUEIRA CD; BUR GE
    Sem Med; 1963 Jul; 123():281-2. PubMed ID: 14091096
    [No Abstract]   [Full Text] [Related]  

  • 2. ADENOMATOID TUMOR OF THE UTERINE TUBE; REPORT OF 2 CASES.
    SCOTT JC; WELCH JS; DOCKERTY MB
    Obstet Gynecol; 1964 Nov; 24():691-4. PubMed ID: 14227599
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vital lymphatic staining of the pelvic lymphnode before panhysterectomy according to the Wertheim-Meigs method for epithelioma of the uterine cervix].
    LUCCHESE A
    Riv Anat Patol Oncol; 1961 Nov; 20():713-7. PubMed ID: 14467108
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of the relationship between clinicopathological features and pelvic lymph node metastasis in patients with early stage squamous cell carcinoma of the uterine cervix].
    Tian QF; Wang XY; Lü WG; Ye F; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct; 43(10):760-3. PubMed ID: 19087544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Glandular inclusions" in the pelvic lymph nodes and endometriosis].
    HUHN FO
    Geburtshilfe Frauenheilkd; 1962 Apr; 22():335-46. PubMed ID: 14449862
    [No Abstract]   [Full Text] [Related]  

  • 6. REGENERATION OF PELVIC LYMPH NODES AFTER PELVIC LYMPHADENECTOMY.
    NELSON JH; ROBERSON JO; MASTERSON JG
    Am J Obstet Gynecol; 1965 Sep; 93():102-9. PubMed ID: 14329157
    [No Abstract]   [Full Text] [Related]  

  • 7. [COMPARATIVE CLINICO-MORPHOLOGICAL STUDIES ON THE DEVELOPMENT OF PRECANCEROUS CONDITIONS AND CANCER OF THE CERVIX UTERI].
    KROTOVA LI
    Vopr Onkol; 1963; 9():26-38. PubMed ID: 14148611
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MULTIFOCAL SQUAMOUS CELL CARCINOMA OF THE CERVIX AND BODY OF THE UTERUS: A CASE REPORT.
    KELKAR SS; KARNIK VR; BHENDE YM
    Indian J Pathol Bacteriol; 1963 Jul; 37():148-53. PubMed ID: 14048933
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of scalene lymph node biopsy in advanced carcinoma of the cervix uteri.
    Buchsbaum HJ; Lifshitz S
    Surg Gynecol Obstet; 1976 Aug; 143(2):246-8. PubMed ID: 941081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The rule of metastatic pelvic lymph node distribution in patients with early stage cervical carcinoma].
    Zhang HY; Sheng XG; Zhong Y; Ma ZF; Ma YB; Liu NF; Chen YT; Wang YY
    Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):452-5. PubMed ID: 19024522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [PELVIC HYSTERECTOMY AND LYMPHADENECTOMY IN THE TREATMENT OF CERVICO-UTERINE CARCINOMA. STUDY ON 100 CASES TREATED AT THE HOSPITAL DE ONCOLOG'IA OF THE CENTRO M'EDICO NACIONAL DEL I.M.S.S].
    CARRANZA JV; CASTILLEJA G; LOPEZCUETO J
    Ginecol Obstet Mex; 1964; 19():425-43. PubMed ID: 14258461
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolated para-aortic lymph node metastasis in FIGO stage IA2-IB2 carcinoma of the cervix: Revisiting the role of surgical assessment.
    Del Carmen MG; Pareja R; Melamed A; Rodriguez J; Greer A; Clark RM; Rice LW
    Gynecol Oncol; 2018 Sep; 150(3):406-411. PubMed ID: 30017539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UNINTENTIONAL REMOVAL OF INVASIVE EPIDERMOID CERVICAL CARCINOMA IN TOTAL HYSTERECTOMY. A TEN YEAR SURVEY AT A PRIVATE HOSPITAL.
    MOORE DW
    Am J Obstet Gynecol; 1964 Jun; 89():320-7. PubMed ID: 14177948
    [No Abstract]   [Full Text] [Related]  

  • 15. Scalene lymph node metastases with the negative pelvic nodes in invasive cervical carcinoma.
    Mai YL; Lin HH; Chang DY; Chen CK; Cheng WF; Tseng GC; Huang SC
    J Formos Med Assoc; 1996 Jan; 95(1):73-5. PubMed ID: 8640102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [ON PRE- AND POSTOPERATIVE ENDOXAN THERAPY OF CERVICAL AND UTERINE CARCINOMA WITH REFERENCE TO HISTOLOGICALLY DISCERNIBLE CHANGES].
    MUELLER R
    Zentralbl Gynakol; 1963 Oct; 85():1489-500. PubMed ID: 14095101
    [No Abstract]   [Full Text] [Related]  

  • 17. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA; van der Velden J; Ten Kate FJ; Schilthuis MS; Hart AA; Lammes FB
    Cancer; 1997 Oct; 80(7):1234-40. PubMed ID: 9317173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage IB carcinoma of the cervix, the Norwegian Radium hospital. II. Results when pelvic nodes are involved.
    Martimbeau PW; Kjorstad KE; Iversen T
    Obstet Gynecol; 1982 Aug; 60(2):215-8. PubMed ID: 7155484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [RECURRENCE OF CANCER OF THE CERVIX UTERI IN RELATION TO INVOLVEMENT OF THE PELVIC LYMPH NODES].
    MACCHIONI B; BOCCI A; RUSSO A
    Minerva Ginecol; 1964 Jan; 16():47-50. PubMed ID: 14129872
    [No Abstract]   [Full Text] [Related]  

  • 20. Prognostic value of cervical size and pelvic lymph node status assessed by computed tomography for patients with uterine cervical cancer treated by radical radiation therapy.
    Toita T; Nakano M; Higashi M; Sakumoto K; Kanazawa K
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):843-9. PubMed ID: 7591892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.